RELMADA THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
RELMADA THERAPEUTICS, INC. (RLMD) reported Increase (Decrease) in Accrued Liabilities of $150.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $1.71M.
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$1.56M.
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $1.13M, a 168.13% increase year-over-year.
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was -$36.14K, a 109.54% decline year-over-year.
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was -$1.30M.
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2024 was -$2.53M, a 270.60% decline from fiscal 2023.
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was $1.48M, a 55.61% decline from fiscal 2022.
- RELMADA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $3.34M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 115 month | Increase (Decrease) in Accrued Liabilities 118 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $150.00K 10-Q · filed 2026-08-06 | $1.28M derived: sum of 3 quarters · filed 2026-08-06 | $1.24M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$1.56M 10-Q · filed 2026-05-12 | -$434.27K derived: sum of 2 quarters · filed 2026-05-12 | -$470.41K derived: sum of 3 quarters · filed 2026-05-12 | -$664.19K derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-12-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $1.09M derived: sum of 2 quarters · filed 2026-03-19 | $895.17K derived: sum of 3 quarters · filed 2026-08-06 | -$1.30M 10-K · filed 2026-03-19 | ||
| 2025-09-30 | -$36.14K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$229.91K derived: sum of 2 quarters · filed 2026-08-06 | -$2.42M 10-Q · filed 2025-11-13 | -$2.00M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-06-30 | -$193.78K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.39M 10-Q · filed 2026-08-06 | -$1.97M derived: sum of 3 quarters · filed 2026-08-06 | -$1.59M derived: sum of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | -$2.19M 10-Q · filed 2026-05-12 | -$1.77M derived: sum of 2 quarters · filed 2026-05-12 | -$1.40M derived: sum of 3 quarters · filed 2026-05-12 | -$3.21M derived: sum of 4 quarters · filed 2026-05-12 | ||
| 2024-12-31 | $419.61K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $798.55K derived: sum of 2 quarters · filed 2026-03-19 | -$1.01M derived: sum of 3 quarters · filed 2026-03-19 | -$2.53M 10-K · filed 2026-03-19 | ||
| 2024-09-30 | $378.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$1.43M derived: sum of 2 quarters · filed 2025-11-13 | -$2.95M 10-Q · filed 2025-11-13 | $175.75K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | -$1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$3.33M 10-Q · filed 2025-08-07 | -$203.19K derived: sum of 3 quarters · filed 2025-08-07 | -$486.57K derived: sum of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | -$1.52M 10-Q · filed 2025-05-12 | $1.61M derived: sum of 2 quarters · filed 2025-05-12 | $1.32M derived: sum of 3 quarters · filed 2025-05-12 | $1.50M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | $3.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $2.84M derived: sum of 2 quarters · filed 2025-03-27 | $3.01M derived: sum of 3 quarters · filed 2025-03-27 | $1.48M 10-K · filed 2025-03-27 | ||
| 2023-09-30 | -$283.38K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$109.83K derived: sum of 2 quarters · filed 2024-11-07 | -$1.64M 10-Q · filed 2024-11-07 | -$4.79M derived: sum of 4 quarters · filed 2024-11-07 | ||
| 2023-06-30 | $173.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$1.36M 10-Q · filed 2024-08-07 | -$4.50M derived: sum of 3 quarters · filed 2024-08-07 | -$5.53M derived: sum of 4 quarters · filed 2024-08-07 | ||
| 2023-03-31 | -$1.53M 10-Q · filed 2024-05-08 | -$4.68M derived: sum of 2 quarters · filed 2024-05-08 | -$5.71M derived: sum of 3 quarters · filed 2024-05-08 | $935.96K derived: sum of 4 quarters · filed 2024-05-08 | ||
| 2022-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | -$4.17M derived: sum of 2 quarters · filed 2024-03-19 | $2.47M derived: sum of 3 quarters · filed 2024-03-19 | $3.34M 10-K · filed 2024-03-19 | ||
| 2022-09-30 | -$1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $5.61M derived: sum of 2 quarters · filed 2023-11-08 | $6.48M 10-Q · filed 2023-11-08 | $4.81M derived: sum of 4 quarters · filed 2023-11-08 | ||
| 2022-06-30 | $6.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $7.51M 10-Q · filed 2023-08-08 | $5.84M derived: sum of 3 quarters · filed 2023-08-08 | $7.92M derived: sum of 4 quarters · filed 2023-08-08 | ||
| 2022-03-31 | $870.90K 10-Q · filed 2023-05-11 | -$799.48K derived: sum of 2 quarters · filed 2023-05-11 | $1.28M derived: sum of 3 quarters · filed 2023-05-11 | $102.74K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$1.67M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $407.60K derived: sum of 2 quarters · filed 2023-03-23 | -$768.16K derived: sum of 3 quarters · filed 2023-03-23 | -$388.56K 10-K · filed 2023-03-23 | ||
| 2021-09-30 | $2.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $902.22K derived: sum of 2 quarters · filed 2022-11-10 | $1.28M 10-Q · filed 2022-11-10 | $2.88M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | -$1.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$796.16K 10-Q · filed 2022-08-11 | $800.00K derived: sum of 3 quarters · filed 2022-08-11 | $2.10M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $379.60K 10-Q · filed 2022-05-05 | $1.98M derived: sum of 2 quarters · filed 2022-05-05 | $3.28M derived: sum of 3 quarters · filed 2022-05-05 | $3.48M derived: sum of 4 quarters · filed 2022-05-05 | ||
| 2020-12-31 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $2.90M derived: sum of 2 quarters · filed 2022-03-25 | $3.10M derived: sum of 3 quarters · filed 2022-03-25 | $3.43M 10-K · filed 2022-03-25 | ||
| 2020-09-30 | $1.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.50M derived: sum of 2 quarters · filed 2021-11-12 | $1.84M 10-Q · filed 2021-11-12 | $1.65M derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $202.56K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $536.00K 10-Q · filed 2021-08-10 | $346.54K derived: sum of 3 quarters · filed 2021-08-10 | $43.08K derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | $333.43K 10-Q · filed 2021-05-12 | $143.98K derived: sum of 2 quarters · filed 2021-05-12 | -$159.49K derived: sum of 3 quarters · filed 2021-05-12 | $137.42K derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2019-12-31 | -$189.45K derived: 10-K 6 month − 10-Q 3 month · filed 2021-03-24 | -$492.92K 10-K · filed 2021-03-24 | -$196.01K derived: sum of 3 quarters · filed 2021-03-24 | -$565.61K 10-K · filed 2021-03-24 | ||
| 2019-09-30 | -$303.46K 10-Q · filed 2019-11-13 | -$6.56K derived: sum of 2 quarters · filed 2020-08-12 | -$376.16K 10-Q · filed 2020-11-12 | $965.51K derived: sum of 4 quarters · filed 2020-08-12 | ||
| 2019-06-30 | $296.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$72.69K 10-Q · filed 2020-08-12 | $1.27M derived: sum of 3 quarters · filed 2020-08-12 | $1.18M 10-K · filed 2021-03-24 | ||
| 2019-03-31 | -$369.60K 10-Q · filed 2020-05-15 | $972.07K derived: sum of 2 quarters · filed 2020-05-15 | $884.37K 10-Q · filed 2019-05-15 | $1.48M derived: sum of 4 quarters · filed 2020-05-15 | ||
| 2018-12-31 | $1.34M derived: 10-KT 6 month − 10-Q 3 month · filed 2020-03-26 | $1.65M 10-KT · filed 2020-03-26 | $1.85M derived: sum of 3 quarters · filed 2020-03-26 | $1.81M derived: sum of 4 quarters · filed 2020-03-26 | ||
| 2018-09-30 | $306.71K 10-Q · filed 2019-11-13 | $507.58K derived: sum of 2 quarters · filed 2020-03-26 | $472.06K derived: sum of 3 quarters · filed 2020-03-26 | $564.59K derived: sum of 4 quarters · filed 2020-03-26 | ||
| 2018-06-30 | $200.87K derived: 10-KT 12 month − 10-Q 9 month · filed 2020-03-26 | $165.36K derived: sum of 2 quarters · filed 2020-03-26 | $257.88K derived: sum of 3 quarters · filed 2020-03-26 | $215.63K 10-KT · filed 2020-03-26 | ||
| 2018-03-31 | -$35.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | $57.01K derived: sum of 2 quarters · filed 2019-05-15 | $14.76K 10-Q · filed 2019-05-15 | -$216.44K derived: sum of 4 quarters · filed 2019-05-15 | ||
| 2017-12-31 | $92.53K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | $50.27K 10-Q · filed 2019-02-13 | -$180.93K derived: sum of 3 quarters · filed 2019-02-13 | -$66.97K derived: sum of 4 quarters · filed 2019-02-13 | ||
| 2017-09-30 | -$42.25K 10-Q · filed 2018-11-13 | -$273.45K derived: sum of 2 quarters · filed 2018-11-13 | -$159.49K derived: sum of 3 quarters · filed 2018-11-13 | -$91.90K derived: sum of 4 quarters · filed 2018-11-13 | ||
| 2017-06-30 | -$231.20K derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-28 | -$117.24K derived: sum of 2 quarters · filed 2018-09-28 | -$49.65K derived: sum of 3 quarters · filed 2018-09-28 | -$279.61K 10-K · filed 2018-09-28 | ||
| 2017-03-31 | $113.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-14 | $181.56K derived: sum of 2 quarters · filed 2018-05-14 | -$48.41K 10-Q · filed 2018-05-14 | -$459.25K derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $67.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-12 | -$162.37K 10-Q · filed 2018-02-12 | -$573.21K derived: sum of 3 quarters · filed 2018-02-12 | -$1.09M derived: sum of 4 quarters · filed 2018-02-12 | ||
| 2016-09-30 | -$229.97K 10-Q · filed 2017-11-14 | -$640.81K derived: sum of 2 quarters · filed 2017-11-14 | -$1.16M derived: sum of 3 quarters · filed 2017-11-14 | -$209.65K derived: sum of 4 quarters · filed 2017-11-14 | ||
| 2016-06-30 | -$410.84K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | -$927.82K derived: sum of 2 quarters · filed 2017-09-28 | $20.32K derived: sum of 3 quarters · filed 2017-09-28 | $152.59K 10-K · filed 2017-09-28 | ||
| 2016-03-31 | -$516.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-15 | $431.16K derived: sum of 2 quarters · filed 2017-05-15 | $563.43K 10-Q · filed 2017-05-15 | $547.20K derived: sum of 4 quarters · filed 2017-05-15 | ||
| 2015-12-31 | $948.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | $1.08M 10-Q · filed 2017-02-10 | $1.06M derived: sum of 3 quarters · filed 2017-02-10 | $940.99K derived: sum of 4 quarters · filed 2017-02-10 | ||
| 2015-09-30 | $132.26K 10-Q · filed 2016-11-10 | $116.04K derived: sum of 2 quarters · filed 2016-11-10 | -$7.15K derived: sum of 3 quarters · filed 2016-11-10 | -$364.97K derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | -$16.22K derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | -$139.42K derived: sum of 2 quarters · filed 2016-09-09 | -$497.23K derived: sum of 3 quarters · filed 2016-09-09 | $244.00 10-K · filed 2016-09-09 | ||
| 2015-03-31 | -$123.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-05-09 | -$481.01K derived: sum of 2 quarters · filed 2016-05-09 | $16.47K 10-Q · filed 2016-05-09 | $294.89K derived: sum of 4 quarters · filed 2016-05-09 | ||
| 2014-12-31 | -$357.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-02-05 | $139.66K 10-Q · filed 2016-02-05 | $418.08K derived: sum of 3 quarters · filed 2016-02-05 | $143.95K derived: sum of 4 quarters · filed 2016-02-05 | ||
| 2014-09-30 | $497.47K 10-Q · filed 2015-11-06 | $775.90K derived: sum of 2 quarters · filed 2015-11-06 | $501.76K derived: sum of 3 quarters · filed 2015-11-06 | $947.86K derived: sum of 4 quarters · filed 2015-11-06 | ||
| 2014-06-30 | $278.42K derived: 10-K 6 month − 8-K 3 month · filed 2015-09-11 | $4.29K 10-K · filed 2015-09-11 | $450.39K derived: sum of 3 quarters · filed 2015-09-11 | $527.26K derived: sum of 4 quarters · filed 2015-09-11 | ||
| 2014-03-31 | -$274.14K 8-K · filed 2014-05-27 | $171.97K derived: sum of 2 quarters · filed 2015-02-13 | $248.84K 10-Q · filed 2015-05-15 | $569.82K 8-K · filed 2014-05-27 | ||
| 2013-12-31 | $446.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-13 | $522.98K 10-Q · filed 2015-02-13 | $315.70K 10-K · filed 2015-09-11 | $843.96K 8-K · filed 2014-05-27 | ||
| 2013-09-30 | $76.88K 10-Q · filed 2014-11-07 | |||||
| 2013-03-31 | $38.46K 8-K · filed 2014-05-27 | |||||
| 2012-12-31 | $369.93K 10-KT · filed 2014-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |